BioMarin Pharmaceuticals Inc. (NASDAQ: BMRN): Truist Financial reiterated a Buy rating with a $133 target price. The consensus target is $113.90. The stock closed on Tuesday at $81.25.
Delek US Holdings Inc. (NYSE: DK): Scotiabank upgraded the stock to Sector Perform from Sector Underperform and has a $35 price objective. The consensus target is $33.33. Tuesday’s close was at $33.43.
Eli Lilly and Co. (NYSE: LLY): Goldman Sachs raised its $281 price target to $313 while maintaining a Neutral rating. The stock hit a new 52-week high of $368.75 on Tuesday and closed at $366.66.
Energy Recovery Inc. (NASDAQ: ERII): Raymond James lifted its Market Perform rating to Outperform with a $23 target. The consensus target is $27.00. The shares closed 7% higher on Tuesday at $20.02 on no news we could source.
Estee Lauder Companies Inc. (NYSE: EL): The Zacks Bear of the Day stock is widely underperforming the general market, points out the analyst. Shares have traded as high as $374.20 apiece in the past year but closed most recently at $207.89. That is down about 23% in the past 90 days.
Freshpet Inc. (NASDAQ: FRPT): Oppenheimer reiterated an Outperform rating and has an $80 target price. The consensus target is $69.12. The last trade for Tuesday hit the tape at $67.82.
Home Depot Inc. (NYSE: HD): Goldman Sachs lowered its $366 price target on the Buyated stock to $329, less than the $349.45 consensus target. The stock closed on Tuesday at $291.14.
IAA Inc. (NYSE: IAA): Jefferies downgraded the stock to Hold from Buy. Its $40 target price is lower than the $50.13 consensus target. The stock closed on Tuesday at $38.14.
Lending Tree Inc. (NASDAQ: TREE): Oppenheimer lowered its $55 price target to $35 while keeping an Outperform rating. The consensus target is $41.89. Tuesday’s close at $24.79 was up over 3% for the day.
Marsh & McLennan Companies Inc. (NYSE: MMC): Atlantic Equities downgraded the stock to Neutral from Overweight, but its $185 price target is higher than the $173.93 consensus target. The stock closed on Tuesday at $161.73.
Medtronic PLC (NYSE: MDT): Stifel reiterated a Buy rating with a $105 target price. The posted consensus target is $105.05, and shares were last seen at $80.19, after retreating over 6% on Tuesday as one of its devices failed on primary goals.
Palantir Technologies Inc. (NYSE: PLTR): Goldman Sachs lowered its price target on the Neutralated stock to $9 from $10. The consensus target is $9.98. Tuesday’s close was at $7.21.
Q2 Holdings Inc. (NYSE: QTWO): Piper Sandler’s downgrade to Underweight from Neutral included a target price cut from $45 to $22. The consensus target is $59.75 for now. The stock closed on Tuesday at $24.40, which was down almost 8% on the day despite beating earnings estimates.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
